AGNG

Aging Population ETF

Overview Prices & Performance Holdings & Characteristics Research Documents

Reasons to Consider AGNG

Long-Term Growth Potential

Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.¹

Demographics Drive Consumption

With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to their distinct consumer preferences.

Unconstrained Approach

The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.

¹WHO, Oct 2021

Key Information As of 02/03/23

Inception Date	05/09/16
Total Expense Ratio	0.50%
Net Assets	$64.36 million
NAV	$27.39
Fact Sheet

ETF Summary

The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

ETF Objective

The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.

Trading Details As of 02/03/23

Ticker	AGNG
Bloomberg Index Ticker	ILNGRNT
CUSIP	37954Y772
ISIN	US37954Y7720
Primary Exchange	Nasdaq
Shares Outstanding	2,350,000
Number of Holdings	97
30-Day Median Bid-Ask Spread	0.27%

Distributions As of 02/03/23

30-Day SEC Yield	0.86%
Distribution Frequency	Semi-Annually

ETF Prices As of 02/03/23

NAV	$27.39	Daily Change	$0.00	0.00%
Market Price	$27.25	Daily Change	-$0.04	-0.15%

As of recent (12/31/22) As of recent (12/31/22)	Fund NAV	Market Price	Index
1 Year	-8.52%	-8.64%	-8.36%
3 Years	4.18%	4.14%	4.39%
5 Years	7.01%	6.89%	7.22%
Since Inception	9.34%	9.65%	9.62%
1 Year	1.75%	1.37%	1.93%
3 Years	5.47%	5.28%	5.69%
5 Years	6.04%	6.00%	6.25%
Since Inception	9.65%	9.96%	9.93%
Year-to-Date	-8.52%	-8.64%	-8.36%
1 Month	-0.75%	-1.42%	-0.70%
3 Months	11.66%	11.59%	11.71%
Since Inception	81.07%	84.53%	84.12%
Year-to-Date	2.71%	2.71%	2.73%
1 Month	2.71%	2.71%	2.73%
3 Months	8.06%	8.12%	8.13%
Since Inception	85.97%	89.53%	89.16%

Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.

Net Assets (%)	Ticker	Name	SEDOL	Market Price ($)	Shares Held	Market Value ($)
3.87	NOVOB DC	NOVO NORDISK A/S-B	BHC8X90	137.32	18,149	2,492,183.67
3.61	LLY	ELI LILLY & CO	2516152	339.08	6,856	2,324,732.48
3.61	REGN	REGENERON PHARMACEUTICALS	2730190	783.13	2,964	2,321,197.32
3.56	BSX	BOSTON SCIENTIFIC CORP	2113434	48.50	47,196	2,289,006.00
3.44	SYK	STRYKER CORP	2853688	283.14	7,813	2,212,172.82
3.23	BMY	BRISTOL-MYERS SQUIBB CO	2126335	74.45	27,932	2,079,537.40
3.21	AMGN	AMGEN INC	2023607	245.17	8,430	2,066,783.10
3.15	ALC SW	ALCON INC	BJT1GR5	76.35	26,591	2,030,098.13
3.01	AZN	ASTRAZENECA PLC-SPONS ADR	2989044	63.44	30,483	1,933,841.52
2.95	JNJ	JOHNSON & JOHNSON	2475833	164.61	11,533	1,898,447.13
2.91	BIIB	BIOGEN INC	2455965	283.63	6,600	1,871,958.00
2.81	ABBV	ABBVIE INC	B92SR70	145.20	12,453	1,808,175.60
2.78	DXCM	DEXCOM INC	B0796X4	108.43	16,491	1,788,119.13
2.56	4519 JP	CHUGAI PHARMA CO	6196408	25.77	63,827	1,644,870.11
2.55	WELL	WELLTOWER INC	BYVYHH4	75.82	21,653	1,641,730.46
2.55	MDT	MEDTRONIC PLC	BTN1Y11	87.10	18,817	1,638,960.70
2.51	RO SW	ROCHE HOLDING AG-BR	7108918	354.63	4,556	1,615,697.39
2.23	EW	EDWARDS LIFESCIENCES CORP	2567116	82.12	17,447	1,432,747.64
1.89	ZBH	ZIMMER BIOMET HO	2783815	129.45	9,410	1,218,124.50
1.85	BGNE	BEIGENE LTD-ADR	BYYWPW6	256.90	4,627	1,188,676.30
1.85	4503 JP	ASTELLAS PHARMA INC	6985383	14.42	82,394	1,188,060.62
1.79	GMAB DC	GENMAB A/S	4595739	388.11	2,973	1,153,843.23
1.76	SGEN	SEAGEN INC	BLPK4D2	138.00	8,225	1,135,050.00
1.59	STMN SW	STRAUMANN HOLDING AG-REG	BQ7ZV06	143.99	7,125	1,025,910.42
1.54	4543 JP	TERUMO CORP	6885074	29.11	34,054	991,162.67
1.47	VTR	VENTAS INC	2927925	52.60	17,935	943,381.00
1.42	PODD	INSULET CORP	B1XGNW4	295.19	3,094	913,317.86
1.37	068270 KS	CELLTRION INC	B0C5YV1	137.55	6,418	882,758.67
1.29	INCY	INCYTE CORP	2471950	83.61	9,927	829,996.47
1.18	SOON SW	SONOVA HOLDING AG-REG	7156036	267.71	2,834	758,682.06
1.11	UCB BB	UCB SA	5596991	81.54	8,731	711,926.02
0.88	SN/ LN	SMITH & NEPHEW PLC	0922320	14.38	39,294	565,169.10
0.86	3692 HK	HANSOH PHARMACEU	BJYKB72	2.09	263,443	550,035.86
0.85	TFX	TELEFLEX INC	2881407	258.47	2,111	545,630.17
0.81	EXAS	EXACT SCIENCES CORP	2719951	67.45	7,766	523,816.70
0.80	UTHR	UNITED THERAPEUTICS CORP	2430412	252.80	2,043	516,470.40
0.79	FME GR	FRESENIUS MEDICA	5129074	38.66	13,099	506,455.22
0.73	NBIX	NEUROCRINE BIOSC	2623911	110.03	4,266	469,387.98
0.72	1858 HK	BEIJING CHUNLI-H	BVVPXP6	2.73	170,266	465,527.86
0.72	COH AU	COCHLEAR LTD	6211798	154.83	2,990	462,935.99
0.69	NVCR	NOVOCURE LTD	BYSS4X4	94.22	4,698	442,645.56
0.63	FGEN	FIBROGEN INC	BSDRYR8	24.57	16,431	403,709.67
0.62	AGL	AGILON HEALTH INC	BLR4TK4	22.05	18,061	398,245.05
0.58	1789 HK	AK MEDICAL HOLDINGS LTD	BFD6SZ0	1.15	326,989	375,116.44
0.57	DVA	DAVITA INC	2898087	85.48	4,298	367,393.04
0.54	DEMANT DC	DEMANT A/S	BZ01RF1	31.91	10,804	344,777.50
0.50	2186 HK	LUYE PHARMA GROUP LTD	BNQ4GF3	0.56	579,824	324,452.52
0.50	HALO	HALOZYME THERAPEUTICS INC	2975098	52.65	6,137	323,113.05
0.48	853 HK	MICROPORT SCIENTIFIC CORP	B676TW7	3.36	91,802	308,335.27
0.48	OHI	OMEGA HEALTHCARE	2043274	28.72	10,719	307,849.68
0.48	AMP IM	AMPLIFON SPA	B14NJ71	30.23	10,157	307,019.26
0.43	MNKD	MANNKIND CORP	BF081J4	5.18	53,629	277,798.22
0.42	SILK	SILK ROAD MEDICAL INC	BGHVXJ7	54.81	4,908	269,007.48
0.39	1302 HK	LIFETECH SCIENTIFIC CORP	BV9FKS0	0.42	609,892	253,431.73
0.39	EXEL	EXELIXIS INC	2576941	17.55	14,357	251,965.35
0.37	MMSI	MERIT MEDICAL SYSTEMS INC	2580555	73.33	3,241	237,662.53
0.36	2500 HK	VENUS MEDTECH -H	BL6V047	2.13	109,940	234,025.21
0.36	ENSG	ENSIGN GROUP INC/THE	B1YWPP8	92.40	2,513	232,201.20
0.36	TBPH	THERAVANCE BIOPHARMA INC	BMNDK09	10.65	21,632	230,380.80
0.35	LHCG	LHC GROUP INC	B06DT50	158.65	1,415	224,489.75
0.34	ATEC	ALPHATEC HOLDINGS INC	BD60BG7	13.48	16,394	220,991.12
0.34	NHI	NATL HEALTH INVESTORS INC	2626125	59.17	3,731	220,763.27
0.34	LTC	LTC PROPERTIES INC	2498788	38.31	5,628	215,608.68
0.33	AGIO	AGIOS PHARMACEUTICALS INC	BCBVTX1	30.20	7,028	212,245.60
0.32	SBRA	SABRA HEALTH CAR	B5NLBP6	13.59	15,094	205,127.46
0.32	SGHT	SIGHT SCIENCES INC	BN2T5Q6	11.54	17,668	203,888.72
0.31	ITGR	INTEGER HOLDINGS CORP	BD06LM7	73.50	2,749	202,051.50
0.31	EKTAB SS	ELEKTA AB-B SHS	B0M42T2	7.47	27,029	201,883.95
0.31	DNLI	DENALI THERAPEUTICS INC	BD2B4V0	31.70	6,310	200,027.00
0.31	4547 JP	KISSEI PHARM CO	6494061	18.77	10,570	198,429.49
0.30	8086 JP	NIPRO CORP	6641599	7.84	24,837	194,844.60
0.29	NUVA	NUVASIVE INC	B00GJC2	48.12	3,869	186,176.28
0.29	NHC	NATIONAL HEALTHCARE CORP	2139731	61.91	2,968	183,748.88
0.28	GKOS	GLAUKOS CORP	BYMWL19	51.52	3,493	179,959.36
0.27	GN DC	GN STORE NORD A/S	4501093	27.68	6,242	172,747.82
0.27	PHM SM	PHARMA MAR SA	BMW2GT8	66.51	2,560	170,273.83
0.26	INGN	INOGEN INC	BJSVLL5	26.00	6,378	165,828.00
0.24	SIA CN	SIENNA SENIOR LIVING INC	BWTYXH4	9.16	16,563	151,648.37
0.23	ACAD	ACADIA PHARMACEU	2713317	19.83	7,586	150,430.38
0.23	LIVN	LIVANOVA PLC	BYMT0J1	58.14	2,568	149,303.52
0.23	AED BB	AEDIFICA	B1G5XP1	90.82	1,618	146,951.97
0.23	CSH-U CN	CHARTWELL RETIRE	B8S8C94	7.34	20,022	146,924.35
0.22	PNTG	PENNANT GROUP INC/THE	BKTC976	12.76	11,293	144,098.68
0.22	RYM NZ	RYMAN HEALTHCARE LTD	6161525	4.27	32,852	140,362.72
0.22	ALEC	ALECTOR INC	BJ4LDC4	9.49	14,683	139,341.67
0.21	BPMC	BLUEPRINT MEDICINES CORP	BWY52P3	45.65	2,986	136,310.90
0.21	AMED	AMEDISYS INC	2024332	92.14	1,448	133,418.72
0.20	ANGO	ANGIODYNAMICS INC	B00CR04	13.43	9,595	128,860.85
0.19	CMAX	CAREMAX INC	BMD9BG0	4.53	27,119	122,849.07
0.16	AMRN	AMARIN CORP PLC -ADR	2301938	1.89	55,853	105,562.17
0.15	HRTX	HERON THERAPEUTICS INC	BJ0XLZ3	2.84	32,757	93,029.88
0.14	KORI FP	KORIAN	B1HKRM0	9.78	9,506	92,993.70
0.13	BKD	BROOKDALE SR	B0PZN33	2.80	30,346	84,968.80
0.13		CASH		1.00	81,880	81,879.88
0.09	CANO	CANO HEALTH INC	BN0WWW2	1.49	36,847	54,902.03
0.08	DHC	DIVERSIFIED HEAL	BKRN595	0.75	71,357	53,160.97
0.03	ORP FP	ORPEA	7339451	3.02	5,277	15,916.60
0.00		EURO		1.09	1	1.39
0.00		BRITISH STERLING POUND		1.17	0	0.07
0.00		DANISH KRONE		0.00	0	0.00
0.00		HONG KONG DOLLAR		0.00	0	0.00
0.00		KOREAN WON		0.00	0	0.00
0.00		SWEDISH KRONE		0.00	0	0.00
0.00		RADIUS HEALTH INC - CVR	2KFF9T0	0.00	19,104	0.00
0.00		JAPANESE YEN		0.01	-2	-0.02
0.00		SWISS FRANC		1.00	0	-0.03
0.00		AUSTRALIAN DOLLAR		0.69	0	-0.09
0.00		CANADIAN DOLLAR		0.74	0	-0.28

Holdings are subject to change. "Cash" denotes U.S. dollars.

Sector Breakdown As of 12/31/22

	Sector	Weight (%)
	Health Care	94.7
	Real Estate	5.3

Source: AltaVista Research, LLC

Country Breakdown As of 12/31/22

	Country	Weight (%)
	United States	59.2
	Switzerland	8.2
	Japan	6.9
	Denmark	6.7
	China	5.2
	Britain	5.0
	Ireland	2.5
	South Korea	1.3
	Belgium	1.3
	Germany	0.7
	Australia	0.7
	Other/Cash	2.3

Source: AltaVista Research, LLC

ETF Characteristics As of 02/03/23

Return on Equity	13.10%
Weighted Avg. Market Cap	61,168 M
	2022	2023
Price-to-earnings	28.31	25.15
Price-to-book value	3.42	3.18

Source: AltaVista Research, LLC

ETF Risk Stats As of 01/31/23

Versus	Beta
S&P 500	0.71
MSCI EAFE	0.71
MSCI Emg. Mkts	0.56
Standard Deviation	18.60%

Source: AltaVista Research, LLC

ETF Research

J.P. Morgan Healthcare Conference: New Catalysts Set to Transform Patient Care

Another Year of Blockbuster Drug and Treatment Approvals Possible in 2023

Q&A With Luba Greenwood on Healthcare Innovation

Latest Premium / Discount As of 02/03/23

NAV	$27.39
Market Price	$27.25
Premium / (Discount)	($0.14)

Current View 2023 Q1 As of 02/03/23

Days at Premium	6
Days at NAV	0
Days at Discount	17
Greatest Premium	0.13%
Greatest Discount	-0.59%

Daily Premium / Discount History As of 02/03/23

Hover over the chart points for details

View Chart Explanation

Download Chart Data (.CSV)

How can the Fund trade at a premium/discount to its NAV?

The primary explanation is that timing discrepancies can arise between the NAV and the trading price of the Fund. Since shares of the Fund trade on the open market, prices are affected by the constant flow of information received by investors, corporations and financial institutions. Depending on how this changing information affects investor sentiment, shares of the Fund may deviate slightly from the value of the Fund's underlying assets. The NAV of the Fund is only calculated once a day (normally at 4:00 p.m. eastern time). As a result, shareholders may pay more than NAV when they buy Fund shares and receive less than NAV when they sell those shares, because shares are purchased and sold at current market prices. However, due to the creation and redemption process that is unique to ETFs, market makers are able to minimize these deviations from NAV by taking advantage of arbitrage opportunities.

What causes these time discrepancies?

Close of Trading Times. Although both the NAV and the daily market price of the Fund are generally calculated based on prices at the closing time of the exchange (generally 4:00 p.m. eastern time), slight differences in this timing may cause discrepancies.

Time of Last Trade. Trading of Global X funds generally takes place during normal trading hours (9:30 a.m. to 4:00 p.m. eastern time). However, it is important to note that the last trade - from which the closing price is determined - may not occur at exactly 4:00 p.m. eastern time. Therefore, changing market sentiment during the time difference may cause the NAV to deviate from the closing price.

International Holdings. The premiums and discounts for funds with significant holdings in international markets may be less accurate due to the different closing times of various international markets. Because the Funds trade during U.S. market hours while the underlying securities may not, the time lapse between the markets can result in differences between the NAV and the trading price.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.

AGNG traded under the ticker LNGR from inception until April 1, 2021.

AGNG

Aging Population ETF

Reasons to Consider AGNG

Long-Term Growth Potential

Demographics Drive Consumption

Unconstrained Approach

Key Information As of 02/03/23

ETF Summary

ETF Objective

Trading Details As of 02/03/23

Distributions As of 02/03/23

ETF Prices As of 02/03/23

Performance History

Top Holdings As of 02/03/23

Sector Breakdown As of 12/31/22

Country Breakdown As of 12/31/22

ETF Characteristics As of 02/03/23

ETF Risk Stats As of 01/31/23

ETF Research

J.P. Morgan Healthcare Conference: New Catalysts Set to Transform Patient Care

Another Year of Blockbuster Drug and Treatment Approvals Possible in 2023

Q&A With Luba Greenwood on Healthcare Innovation

ETF Documents